Biomimetic cardiac tissue chip and murine arteriovenous fistula models for recapitulating clinically relevant cardiac remodeling under volume overload conditions.
arteriovenous fistula
cardiac remodeling
end stage renal disease
heart failure
tissue chip
tissue engineering
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
11
2022
accepted:
03
02
2023
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Cardiovascular events are the primary cause of death among dialysis patients. While arteriovenous fistulas (AVFs) are the access of choice for hemodialysis patients, AVF creation can lead to a volume overload (VO) state in the heart. We developed a three-dimensional (3D) cardiac tissue chip (CTC) with tunable pressure and stretch to model the acute hemodynamic changes associated with AVF creation to complement our murine AVF model of VO. In this study, we aimed to replicate the hemodynamics of murine AVF models
Identifiants
pubmed: 36873372
doi: 10.3389/fbioe.2023.1101622
pii: 1101622
pmc: PMC9978753
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1101622Informations de copyright
Copyright © 2023 Waldrop, Graham, Gard, Ingle, Ptacek, Nguyen, Lose, Sethu and Lee.
Déclaration de conflit d'intérêts
Author TL is a consultant for BD Bard. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Pharmacol. 2021 Jun 14;12:678886
pubmed: 34194329
Biofabrication. 2022 Jun 28;14(3):
pubmed: 35688123
Biomaterials. 2022 Jan;280:121254
pubmed: 34836683
Stain Technol. 1982 Jul;57(4):207-10
pubmed: 6183794
Mol Cell Biochem. 2022 Jun;477(6):1865-1872
pubmed: 35334035
J Vasc Access. 2023 Jan;24(1):124-132
pubmed: 34144670
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cardiovasc Eng Technol. 2017 Sep;8(3):244-254
pubmed: 28695442
Front Pharmacol. 2022 Jul 13;13:918335
pubmed: 35910357
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Regen Ther. 2019 Oct 01;11:297-305
pubmed: 31667209
J Am Coll Cardiol. 2016 Aug 2;68(5):473-482
pubmed: 27470455
Theor Biol Med Model. 2017 Mar 20;14(1):5
pubmed: 28320412
Int J Nephrol Renovasc Dis. 2014 Sep 16;7:337-45
pubmed: 25258554
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Cell Mol Med. 2017 Aug;21(8):1492-1502
pubmed: 28296029
Am J Hypertens. 2019 Aug 14;32(9):858-867
pubmed: 31150056
IEEE Trans Biomed Eng. 2019 Dec;66(12):3436-3443
pubmed: 30892197
J Vasc Access. 2021 Nov;22(1_suppl):32-41
pubmed: 33143540
Cell Mol Life Sci. 2014 Feb;71(4):549-74
pubmed: 23649149
Nefrologia. 2015;35(3):234-45
pubmed: 26299166
Cardiovasc Toxicol. 2011 Jun;11(2):180-90
pubmed: 21431998
Am J Physiol. 1982 Dec;243(6):H941-7
pubmed: 6216817
Am J Hypertens. 2022 Feb 1;35(2):149-155
pubmed: 34655294
Nephrol Dial Transplant. 2008 Jan;23(1):282-7
pubmed: 17942475
Nat Protoc. 2019 Oct;14(10):2781-2817
pubmed: 31492957
Mol Aspects Med. 2019 Feb;65:70-99
pubmed: 30056242